title: Targeting Cancer at the Nuclear Pore.
authors.affiliation: Asfar S. Azmi and Ramzi M. Mohammad, Wayne State University School of Medicine, Detroit, MI.
authors.forename: Asfar S
authors.initials: AS
authors.lastname: Azmi
authors.affiliation: Asfar S. Azmi and Ramzi M. Mohammad, Wayne State University School of Medicine, Detroit, MI.
authors.forename: Ramzi M
authors.initials: RM
authors.lastname: Mohammad
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D028884:Karyopherins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D022022:Nuclear Pore / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018160:Receptors, Cytoplasmic and Nuclear / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D016896:Treatment Outcome; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000097606:Exportin 1 Protein
chemical_list: D000970:Antineoplastic Agents; D006834:Hydrazines; D028884:Karyopherins; D018160:Receptors, Cytoplasmic and Nuclear; D014230:Triazoles; D000097606:Exportin 1 Protein; C585161:selinexor